Document is current
Any future updates will be listed below
-
Authors
Plichta, Jennifer K. https://orcid.org/0000-0002-7411-0558
Ren, Yi
Marks, Caitlin E.
Thomas, Samantha M.
Greenup, Rachel A.
Rosenberger, Laura H.
Fayanju, Oluwadamilola M.
McDuff, Susan G. R.
Hwang, E. Shelley
Force, Jeremy
-
Funding
Funding for this research was provided by:
National Institutes of Health (1K08CA241390, P30CA014236)
- License Information
-
More Information
Article History
Received: 25 May 2020
Accepted: 30 June 2020
First Online: 23 July 2020
Disclosures
: :The authors report no proprietary or commercial interest in any product mentioned or concept discussed in this article. Dr. J. Plichta is a recipient of research funding by the Color Foundation (PI: Plichta). She serves on the NCCN Breast Cancer Screening Committee and the ASCO Clinical Practice Guideline Committee for the Management of Male Breast Cancer. Dr. E.S. Hwang serves on the NCI Breast Cancer Steering Committee and the NCCN Breast Cancer Prevention Committee. The content of this manuscript is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. Samantha Thomas: Consulting work with Abbvie, Inc, on biosimilar/bioequivalence. Unrelated to this work. Relationship complete effective January 2019. Jeremy Force: METAVIVOR Early Career Investigator Award.
